Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Nerviano Medical Sciences discovers new B-raf inhibitors for cancer therapy

April 23, 2010

BAL-30072 active against beta-lactamase-producing enterobacteria in vivo

April 23, 2010

Cempra presents preclinical and clinical phase I data on CEM-101 antibiotic

April 23, 2010

Clinical data support safety and efficacy of BI-207127 plus PEG-IFN/RBV in HCV genotype 1

April 23, 2010

Pfizer describes new oxazolidinone antibacterial

April 22, 2010

Cheminpharma presents preclinical data on new MEK 1 inhibitor

April 22, 2010

Preclinical and phase I data presented on antimicrobial pleuromutilin BC-3781

April 22, 2010

Characterization of filibuvir resistance in HCV patients when coadministered with PEG-INF/RBV

April 22, 2010

Gilead discloses clinical data on HCV NS3 protease inhibitor GS-9256

April 22, 2010

SCH-900776 sensitizes cancer cells to hydroxyurea and gemcitabine

April 21, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...